This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Georgia Research Foundation Inc. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Chaitanya Tondepu: Innovator in Microfluidic Technology
Introduction
Chaitanya Tondepu is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of microfluidics, particularly in the development of devices that mimic biological environments for research purposes. His innovative work aims to enhance the understanding of immune cell interactions with tumor cells.
Latest Patents
Chaitanya Tondepu holds a patent for a "Vascular flow-based microfluidic platform." This microfluidic assay device is designed to replicate in vitro the in vivo biological environment. It supports endothelization and allows for perfusive flow that simulates in vivo blood flow conditions. The device facilitates realistic interactions between T-cells and solid tumor cells, such as glioblastoma multiforme tumor cells. Additionally, it provides methods for studying these interactions and developing improved immunotherapeutic approaches against cancers.
Career Highlights
Chaitanya is associated with the University of Georgia Research Foundation Inc., where he continues to advance his research in microfluidic technologies. His work is pivotal in the ongoing quest to improve cancer treatment methodologies.
Collaborations
Chaitanya collaborates with notable colleagues, including Lohitash Karumbaiah and Meghan T Logun. Their combined expertise contributes to the innovative research being conducted in the field of cancer immunotherapy.
Conclusion
Chaitanya Tondepu's contributions to microfluidic technology and cancer research exemplify the impact of innovative thinking in the medical field. His work not only enhances scientific understanding but also paves the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile